DRUG
Closed
Bright Minds Biosciences Inc
26.58
+0.47 (+1.80%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 26.11
Day's Range: 25.2576 - 26.64
Send
sign up or login to leave a comment!
When Written:
0.4401
Bright Minds Biosciences Inc. is a biotechnology company that specializes in the development of novel treatments for neuropsychiatric disorders. The company is focused on discovering and developing innovative therapies for conditions such as depression, anxiety, addiction, and schizophrenia, among others.
Bright Minds Biosciences uses a proprietary drug discovery platform based on a combination of computational modeling, machine learning, and experimental validation. This approach allows the company to identify and optimize drug candidates with high specificity and efficacy for their target diseases.
The company's lead drug candidate is a novel psychedelic compound with potential therapeutic applications in depression and anxiety. Bright Minds Biosciences is also exploring other compounds with potential applications in addiction and schizophrenia.
Bright Minds Biosciences was founded in 2018 and is headquartered in Vancouver, Canada. The company is led by a team of experienced biotech executives and scientists with a track record of successful drug development.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Bright Minds Biosciences uses a proprietary drug discovery platform based on a combination of computational modeling, machine learning, and experimental validation. This approach allows the company to identify and optimize drug candidates with high specificity and efficacy for their target diseases.
The company's lead drug candidate is a novel psychedelic compound with potential therapeutic applications in depression and anxiety. Bright Minds Biosciences is also exploring other compounds with potential applications in addiction and schizophrenia.
Bright Minds Biosciences was founded in 2018 and is headquartered in Vancouver, Canada. The company is led by a team of experienced biotech executives and scientists with a track record of successful drug development.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








